Orchestra BioMed Holdings Inc. (NASDAQ: OBIO) Stock Information | RedChip

Orchestra BioMed Holdings Inc. (NASDAQ: OBIO) Listen to this Section


$6.35
+0.2900 ( +4.79% ) 23.1K

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

Market Data


Open


$6.35

Previous close


$6.06

Volume


23.1K

Market cap


$242.83M

Day range


$6.02 - $6.52

52 week range


$4.22 - $11.69

Insider Ownership Transactions

Total Amount Purchased: -3,441,995.00 | $ -21,856,668.25

Date Type Amount Purchased Purchaser
2024-08-08 Sale -12864.00 Mack John Prosper
2024-08-07 Sale -3405251.00 HSAC 2 Holdings, LLC
2024-06-26 Buy 1000.00 Hochman David P
2024-06-21 Sale -5376.00 Fain Eric S
2024-06-21 Sale -5376.00 Connealy Pamela Ann
2024-06-21 Sale -5376.00 Pacitti David
2024-06-21 Sale -5376.00 ROSE ERIC A MD
2024-06-21 Sale -5376.00 Aryeh Jason
2024-06-03 Buy 4000.00 Little William Reed
2024-05-20 Sale -2000.00 Hochman David P

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Aug 15, 2024
10-q Quarterly Reports 92 Aug 12, 2024
8-k 8K-related 18 Aug 12, 2024
4 Insider transactions 1 Aug 08, 2024
4 Insider transactions 1 Aug 07, 2024
8-k 8K-related 14 Jul 30, 2024
3 Insider transactions 2 Jul 30, 2024
3 Insider transactions 1 Jul 17, 2024
4 Insider transactions 1 Jun 26, 2024
4 Insider transactions 1 Jun 21, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.